Arkansas recalls
3700 federal recalls on file affecting Arkansas - 321 Arkansas-specific plus 3379 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-02-11FDA-DeviceBoston ScientificClass INationwideContact your doctor about AXIOS Stent
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-DeviceBoston ScientificClass INationwideCheck HOT AXIOS Stent lot numbers immediately
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-DeviceBoston ScientificClass INationwideContact your doctor about Boston Scientific AXIOS Stent
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-DeviceBoston ScientificClass INationwideContact your doctor about AXIOS Stent recall
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-DeviceBoston ScientificClass INationwideStop using Boston Scientific AXIOS Stent
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-FoodB.C. Williams Bakery ServiceClass INationwideStop using B.C. Williams Swiss Chocolate Cake Mix
Undeclared Milk Allergen
- 2026-02-11FDA-FoodB.C. Williams Bakery ServiceClass INationwideStop using B.C. Williams Bakery Bread and Roll Mix
Undeclared Milk Allergen
- 2026-02-11FDA-FoodB.C. Williams Bakery ServiceClass INationwideStop using B.C. Williams Spice Cake Mix
Undeclared Milk Allergen
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam strawberry sea moss gel
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam sea moss gel
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam mango sea moss gel
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodEverpress JuiceClass IStop drinking Everpress Juice cashew coffee milk
Under-processed product may contain pathogenic bacteria that could harm to humans.
- 2026-02-11FDA-FoodEverpress JuiceClass IStop drinking Everpress Juice cashew milk
Under-processed product may contain pathogenic bacteria that could harm to humans.
- 2026-02-11FDA-FoodEverpress JuiceClass IStop drinking Everpress Juice spicy lemonade
Under-processed product may contain pathogenic bacteria that could harm to humans.
- 2026-02-11FDA-FoodEverpress JuiceClass IStop drinking Everpress Juice products
Under-processed product may contain pathogenic bacteria that could harm to humans.
- 2026-02-11FDA-FoodEverpress JuiceClass IStop drinking Everpress pineapple mint juice
Under-processed product may contain pathogenic bacteria that could harm to humans.
- 2026-02-11FDA-FoodEverpress JuiceClass IStop drinking Everpress Juice raw sweet greens
Under-processed product may contain pathogenic bacteria that could harm to humans.
- 2026-02-11FDA-FoodEverpress JuiceClass IStop using Everpress Juice DETOX GREENS
Under-processed product may contain pathogenic bacteria that could harm to humans.
- 2026-02-11FDA-FoodOptiwizeClass IIINationwideStop using OptiWize Collagen Plus
The firm initiated a voluntary recall after NSF testing showed that labeled ingredient quantities did not align with analytical test results, manganese level was below label quantity.
Get notified about new Arkansas recalls
Free weekly digest. Add Arkansas to your profile to filter alerts to your state.
Get the Sunday Brief